Nurse Practitioner in Rye, NY Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Nicole Ashley Levin-akiwumi-assani, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8960 Fax: 914-848-8965 |
Ms. Caitlin Ann Powers, NP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1 Theall Rd, Suite 101, Rye, NY 10580 Phone: 914-848-8773 Fax: 914-848-8761 |
Lauren Einfrank, NP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 101 Theall Rd, Rye, NY 10580 Phone: 914-925-8254 Fax: 914-231-8749 |
Michelle Beltran, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 21 Purchase St, Rye, NY 10580 Phone: 914-471-0139 |
Lisa J Luehman, FNP-BC, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8800 Fax: 914-848-8801 |
News Archive
Gilead Sciences reviewing Notice Letter regarding Teva Pharmaceuticals' generic Viread ANDA
Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Viread® (tenofovir disoproxil fumarate).
Timely acute care reduces total stroke and TIA costs
New research published in the journal Age and Ageing suggests that timely acute care immediately after a stroke reduces the level of disability in stroke survivors and the associated need for long-term care, therefore reducing aftercare costs.
FDA wants clear warnings on ADHD drugs
The Food and Drug Administration (FDA) in the United States has ordered drugmakers to alert patients to the possible cardiovascular and psychiatric risks attached to drugs used to treat attention deficit hyperactivity disorder (ADHD).
New study raises hope to successfully fight chytridiomycosis
An international team of researchers has made important progress in understanding the distribution of the deadly amphibian chytrid pathogen. In some regions, the deadly impact of the pathogen appears to be hampered by small predators, naturally occurring in freshwater bodies. These micropredators may efficiently reduce the number of free-swimming infectious stages (zoospores) by consuming them. This natural behavior will reduce the infection pressure on potential amphibian hosts and a goes a long way towards explaining the occurrence of chytridiomycosis, at least in temporal climatic regions.
Mission Pharmacal, March of Dimes to distribute healthy pregnancy, healthy baby education materials
Mission Pharmacal announced today that it will partner with the March of Dimes to distribute healthy pregnancy and healthy baby education materials to more than 15,000 obstetricians and gynecologists nationwide to help more babies be born healthy.
› Verified 1 days ago